KVN Pharmaceuticals

01/01/2026

*"Wishing you a year of robust health and enduring prosperity. At KVN Pharmaceuticals, we believe that wellness is the foundation of every success. May 2026 be your healthiest and most rewarding year yet. Happy New Year 2026!"

25/12/2025

Most standard allergy pills only block one of these. Monticast-LC combines two different drugs to block both pathways at the same time, giving more complete relief.
​Here is the breakdown of how they work together:
​1. Levocetirizine (The "Anti-Itch" Shield)
​Target: It blocks Histamine.
​What it does: When you are exposed to an allergen (like pollen or dust), your body releases histamine instantly. This causes the "wet and itchy" symptoms.
​Best for:
​Sneezing
​Runny nose
​Itchy, watery eyes
​Itchy throat
​2. Montelukast (The "Anti-Swelling" Shield)
​Target: It blocks Leukotrienes.
​What it does: Leukotrienes are released slightly later than histamine and cause inflammation and tightening. They are responsible for the "stuffy and blocked" feeling.
​Best for:
​Nasal Congestion: (Antihistamines often fail to clear a blocked nose; Montelukast is much better at this).
​Airway Tightening: It relaxes the airways, which is why the image mentions it is good for patients with concomitant asthma.
​The "Synergistic" Effect
​By combining them, you attack the allergy from two sides:
​Levocetirizine stops the immediate irritation (sneezing/itching).
​Montelukast stops the deep inflammation (stuffiness/congestion).
​In simple terms: Levocetirizine dries up the "running," and Montelukast opens up the "blockage."

18/12/2025

SABACURE® (Levosalbutamol) Nebpules
SABACURE® Nebpules contain Levosalbutamol, the R-enantiomer of salbutamol, a selective short-acting β₂-agonist (SABA) used for rapid relief of bronchospasm in patients with asthma, COPD, and other obstructive airway diseases.
It provides effective bronchodilation with a better tolerability profile and reduced β-mediated side effects compared to racemic salbutamol.
Available Strengths (Each 2.5 mL Nebpule):
SABACURE® 0.31 mg – For pediatric patients and dose titration
SABACURE® 0.63 mg – For mild to moderate bronchospasm
SABACURE® 1.25 mg – For moderate to severe bronchospasm in adults
Key Highlights:
Rapid onset of action
Suitable for all age groups (as prescribed)
Ideal for acute exacerbations and nebulization
Consistent drug delivery via nebulization
For use under the supervision of a registered medical practitioner.
Kvn Pharmaceuticals

12/12/2025

Sabacure (Levosalbutamol Nebpules)
A selective β2-agonist providing rapid bronchodilation.
Helps relieve acute bronchospasm with improved tolerability vs racemic salbutamol.
Useful in asthma exacerbations where rapid airway opening is needed.
🔹 Budecure (Budesonide Nebpules)
An inhaled corticosteroid (ICS) for controlling airway inflammation.
Reduces airway hyper-responsiveness, mucus edema, and frequency of exacerbations.
Preferred in moderate to severe asthma or during worsening symptoms.
“In asthma care, rapid bronchodilation and inflammation control are key.
Sabacure (Levosalbutamol) offers quick symptom relief, while Budecure (Budesonide) helps control airway inflammation.
Nebpules ensure effective delivery even in children, elderly, and patients with poor inhaler technique.
Choose smart nebulization for better asthma outcomes.”

09/12/2025

www.kvnpharma.com

We're not here to chase titles — we're here to earn trust. Every day, we work to make healthcare more caring, more human, and more accessible.

07/12/2025

Pulmocure Nebpules (Formoterol + Budesonide) – Clinical Brief for OAD Management
Rationale in OAD:
The LABA–ICS combination remains a cornerstone in the management of Asthma, COPD, and ACO, especially in patients with persistent symptoms and airway inflammation.
Pharmacological Advantages:
Formoterol
Rapid onset (∼1–3 min) with long-acting bronchodilation (up to 12 hours).
Improves FEV₁, reduces dynamic hyperinflation, and enhances exercise tolerance.
Budesonide
Potent anti-inflammatory corticosteroid with high receptor affinity.
Reduces eosinophilic inflammation, mucosal edema, and airway hyperresponsiveness.
Fewer systemic side effects due to extensive first-pass metabolism.
Clinical Integration:
Proven efficacy in reducing exacerbation frequency and hospitalizations in OAD.
Beneficial for patients with poor inhaler technique, ensuring consistent drug delivery.
Nebulized route supports use in acute symptoms, elderly, pediatric, and co-morbid patients where coordination is compromised.
Therapeutic Outcomes:
Better symptom control and night-time relief
Improved pulmonary function
Enhanced adherence due to ease of use
Optimized deposition across variable inspiratory flows

25/11/2025

Winter brings more cough, cold, and asthma flare-ups in children.
Timely nebulization can make breathing easier.
Under a doctor’s guidance, Budecure helps provide fast and effective relief.
Keep your child’s lungs protected this season. ❄️💨

22/11/2025

Our BNP (Best Nebulization Practice) is a continuous effort to promote safe, scientific, and standardized nebulization techniques across healthcare settings.
Through workshops, training sessions, and awareness drives, the campaign focuses on:
✔ Correct nebulization technique
✔ Avoiding common device-handling errors
✔ Ensuring effective drug delivery for faster relief
✔ Training paramedics, nurses & frontline healthcare workers
✔ Building confidence in evidence-based respiratory care
“Right Technique • Right Care • Better Breathing”

21/11/2025

With pollution levels rising, breathing problems are increasing daily.
Nebpules offer a convenient and effective option for relief.
Consult your doctor today about nebulization therapy.
Adopt Best Nebulization Practice (BNP) for better respiratory health.
KVN Pharmaceuticals – Your trusted partner in nebulization care .
#